Papivax
Taiwan - Taipei
BiotechnologyFocus: HPV Vaccines
Papivax is a life sciences company focused on HPV Vaccines.
Infectious DiseasesVaccines
Funding Stage
PUBLIC
Open Jobs
1
Pipeline & Clinical Trials
Personalized Neoantigen DNA vaccine
Unmethylated GlioblastomaClinical Trials (1)
NCT05743595Neoantigen-based Personalized DNA Vaccine With Retifanlimab PD-1 Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma
Phase 1pNGVL4a-Sig/E7
HPV 16 InfectionClinical Trials (1)
NCT06508138Clinical Trial Assessing the Safety and Immunologic Correlates of Heterologous Prime-Boost With pNGVL4a-Sig/E7(Detox)/HSP70 and TA-HPV in Healthy Donors Followed by Peripheral Blood Collection
Phase 1Phase 1
Clinical Trials (1)
NCT02405221Safety and Feasibility of TA-CIN Vaccine in HPV16 Associated Cervical Cancer
Phase 1CD8 reduced peripheral blood cells taken from related donors vaccinated against HPV16
HPV 16+ Recurrent or Metastatic CancerClinical Trials (1)
NCT04713046Safety and Efficacy of Allogeneic HPV-specific T Cells in Adults With Recurrent or Metastatic HPV16+ Cancers
Phase 1/2PVX4 Combination Product
Cervical Intraepithelial Neoplasia Grade 2/3Clinical Trials (1)
NCT07454915PVX4 for the Treatment of HPV16+ Cervical Dysplasia
Phase 2PVX-2
ASC-USClinical Trials (1)
NCT03911076Phase II Study of Treatment for HPV16+ ASC-US, ASC-H and LSIL
Phase 2Open Jobs (1)
Interview Prep Quick Facts
Portfolio: 6 clinical trials
Open Roles: 1 active job